IPA’s Newsletter

IPA’s Newsletter

Home
Archive
About

May 2022

March 2022

January 2022

SARS-CoV-2-targeting monoclonal antibody therapies: A complementary strategy to vaccination.
Vaccines are a cornerstone of the battle against COVID-19, caused by SARS-CoV-2 virus.
 • 
ImmunoPrecise Antibodies
 and 
Rudi Licht, Ph.D
The Origin & Drivers of Virus Variants
Viruses, such as SARS-CoV-2, continuously evolve as changes in the genetic code (mutations) occur as natural by-products of viral replication.
 • 
ImmunoPrecise Antibodies
, 
Hillary Wen
, 
Naushin Hooda
, and 
Rudi Licht, Ph.D
SARS-CoV-2 Infection Process
In the previous article, Introduction to COVID-19 , we discussed the clinical presentation of COVID-19.
 • 
ImmunoPrecise Antibodies
 and 
Halina Lam
Introduction to COVID-19
On March 11th, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic.
 • 
ImmunoPrecise Antibodies
 and 
Hillary Wen

November 2021

Breaking it Down: Parts of a Virus
A virus is an acellular, parasitic entity, that is challenging to classify in the kingdom of living organisms because it is not considered to be alive.
 • 
ImmunoPrecise Antibodies
 and 
Naushin Hooda
Antibody Mediated Immunity vs Cell Mediated Immunity
In our first article, Immunology 101: Innate and Adaptive Immunity Explained, we briefly introduced the concepts of the humoral immune response and the…
 • 
ImmunoPrecise Antibodies
 and 
Halina Lam
Monoclonal Antibody Therapy vs Vaccines
Introduction
 • 
ImmunoPrecise Antibodies
 and 
Halina Lam
1

September 2021

© 2025 ImmunoPrecise Antibodies
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture